HELX
Franklin Genomic Advancements ETF [HELX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HELX Stock Summary
Top 10 Correlated ETFs
HELX
Top 10 Correlated Stocks
HELX
In the News
HELX Financial details
Company Rating
-
Market Cap
9.64M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
4.11%
SMA50
-1.45%
SMA100
-8.51%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
25.26-32.921
52W High
-14.69%
52W Low
+9.2%
RSI
58.66
Rel Volume
0.85
Avg Volume
968
Volume
820
Perf Week
1.83%
Perf Month
1.56%
Perf Quarter
-6.09%
Perf Half Y
-11.31%
-
-
-
-
Beta
1.15
-
-
Volatility
0.34%, 0.62%
Prev Close
-0.91%
Price
27.3
Change
-0.91%
Company Profile
- Volume Average 968
- Market Capitalization 9.64M
- Headquarters US
- IPO Date 2020-02-27
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
